Solaris Pharma Corporation31. May 2021 | Active Investments, Angel Investments, Health and Pharmaceuticals The American pharmaceutical company develops specialised, generic and brand-name dermatology products in niche markets, including the acne gel CLINDAMYCIN PHOSPHATE.Hauptsitz: Bridgewater (NJ), USAGründungsjahr: 2014Start der Investition: 2016